0001203311-18-000099.txt : 20181204 0001203311-18-000099.hdr.sgml : 20181204 20181204193754 ACCESSION NUMBER: 0001203311-18-000099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181130 FILED AS OF DATE: 20181204 DATE AS OF CHANGE: 20181204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIMES VAUGHN B CENTRAL INDEX KEY: 0001361966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 181218314 MAIL ADDRESS: STREET 1: C/O SEATTLE GENETICS, INC. STREET 2: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-11-30 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001361966 HIMES VAUGHN B 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Technical Officer Common Stock 2018-11-30 4 S 0 4600 62.09 D 172729 D Common Stock 2018-11-30 4 S 0 400 62.76 D 172329 D Common Stock 2018-11-30 4 M 0 5000 12.0 A 177329 D Non-Qualified Stock Option (right to buy) 12.0 2018-11-30 4 M 0 5000 0.0 D 2020-08-27 Common Stock 5000 36498 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Reflects sales of common stock executed in multiple transactions at prices ranging from $61.62 to $62.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Reflects sales of common stock executed in multiple transactions at prices ranging from $62.64 to $62.87. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Shares vested at a rate of 25% on 8/27/11 and monthly thereafter until all the shares were fully vested on 8/27/14. By: /s/ Jean Liu For: Vaughn B. Himes 2018-12-04